Gene Green: “I fear that in this instance it would undermine this infant market and create a race to the bottom.”

I hope we all agree on the importance of 340B and the need to stretch scarce federal resources as far as possible to reach more eligible patients and provide more comprehensive services.

It is the hope of our committee and Congress that these investments are being put towards finding a cure for many of our nation's biggest medical priorities.

I look forward to hearing from our panelists regarding their experience with MIPS and recent changes made by Congress.

The promise of the 21st Century Cures Act is to advance the discovery and development of new treatments and cures through increased research and an improved drug approval process.